You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Litigation Details for JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patent cited in this case is ⤷  Try a Trial .

Details for JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-03-19 11 an action for patent infringement of United States Patent No. 9,439,906 (the “’906 patent”). …an action for patent infringement of United States Patent No. 9,439,906 (the “’906 patent”) and that said…BACKGROUND 7. U.S. Patent No. 9,439,906 (the “’906 patent”) is entitled “Dosing Regimen …purports to state an action for patent infringement arising under the Patent Laws of the United States, 35… THE PATENT-IN-SUIT 29. Defendants admit that the face of the ’906 patent lists the External link to document
2021-06-03 237 Order on Motion for Miscellaneous Relief and Mahesh Samtani as inventors of U.S. Patent No. 9,439,906 is GRANTED, etc. Signed by Magistrate Judge… 16 November 2021 2:18-cv-00734 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-10-08 267 Order invalidity of Claims 1–21 of U.S. Patent No. 9,439,906 (the “’906 Patent”). 2. Defendant does…Defendant. CECCHI, District Judge. This patent case was brought by Plaintiffs Janssen Pharmaceuticals… deem Teva’s pleadings amended with a count for patent invalidity under 35 U.S.C. § 102(f). …finding of invalidity shall issue as to the ’906 Patent; and it is further ORDERED that pursuant… Defendant infringes Claims 1–21 of the ’906 Patent; and it is further ORDERED that the parties External link to document
2021-11-15 271 Opinion of Claims 1–21 of U.S. Patent No. 9,439,906 (the “’906 Patent” or the “Patent-in-Suit”). ECF No. 133… and Mahesh Samtani as inventors of U.S. Patent No. 9,439,906.” ECF No. 166 at 1. 54 Plaintiffs rely…blocking patents are the ’544 Patent, U.S. Patent No. 5,254,556 (the “’556 Patent”), and U.S. Patent No.…548 Protocol”); (2) U.S. Patent No. 6,555,544 (the “’544 Patent”), a patent assigned to Plaintiff Janssen…identified U.S. Patent No. 5,352,459 (the “’459 Patent”) as a fourth alleged blocking patent in a pretrial External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.